BioSpace News Archive

Zymo Research Corp., in collaboration with the Institute of Virology, University Medical Center Freiburg, Germany, demonstrated data showing their DNA/RNA Shield™ Inactivating Transport Medium (ITM) completely inactivated recent Monkeypox virus isolates.

Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the appointment of Ms. Pascale Nini to the Board of Directors. In addition, Mr. Thomas Bergmann was appointed as the Company’s independent Chairman.

Novarad™ announced the publication of the article Augmented Reality Spine Surgery Navigation: Increasing Pedicle Screw Insertion Accuracy for Both Open and Minimally Invasive Spine Surgeries authored by surgeons participating from University of Utah, Georgetown University and University of Washington in the June 2022 issue of SPINE (volume 47, number 12).

CANbridge Pharmaceuticals Inc. (HKEX:1228), announced that the first patient has been dosed in the Phase 2 EMBARK study of CAN108 (maralixibat) in biliary atresia (BA) in China, at Children’s Hospital of Capital Institute of Pediatrics (CIP), in Beijing.

Burning Rock Biotech Limited, a company focused on the application of next generation sequencing technology in the field of precision oncology, announced the resignation of Ms. Yunxia Yang as a director from the board of directors of the Company and a member of the compensation committee of the Board.

Maleth Program is the first space bioscience project led by Professor Joseph Borg of the University of Malta.